New! Sign up for our free email newsletter.
Science News
from research organizations

Putting COVID-19 diagnostic tests to the 'test' -- how do they hold up?

Date:
June 10, 2020
Source:
York University
Summary:
As SARS-CoV-2 has the potential to mutate, it is important to check the efficacy of current diagnostic tests, say researchers, who found seven out of 27 methods had potential sequence mismatch issues that may lead to underperforming or false-negative COVID-19 test results.
Share:
FULL STORY

As SARS-CoV-2 has the potential to mutate, it is important to check the efficacy of current diagnostic tests, say York University researchers, who found seven out of 27 methods had potential sequence mismatch issues that may lead to underperforming or false-negative COVID-19 test results.

Many of the tests were developed early in the outbreak when the virus was first identified and sequenced. The researchers say it is important to re-evaluate them periodically to ensure they still work.

"COVID-19 tests use polymerase chain reaction (PCR) assays to diagnose the virus in patients, but if those assays are mismatched due to genetic variability in the viral genome, that raises the concern that the tests may not be detecting all the circulating variants of the virus and results could be inaccurate," says York research associate Kashif Aziz Khan, corresponding author of a new study published today in the journal Royal Society Open Science with Associate Professor Peter Cheung of the Faculty of Science.

Correcting any mismatches between the assays and the SARS-CoV-2 genome may help to improve the sensitivity and accuracy of some of the diagnostic tests.

The early sequencing of the virus allowed for the development of several PCR detection protocols by multiple national organizations that were published by the World Health Organization (WHO), but it may have also led to tests that do not account for variations and mutations.

This is not uncommon with viruses and has led at times to improper diagnosis of influenza, dengue, rabies, respiratory syncytial virus, hepatitis B and human immunodeficiency virus.

The researchers tested genetic variations in more than 17,000 publicly available viral genome sequences worldwide and performed an exhaustive evaluation of 27 published diagnostic PCR assays, including those recommended by the WHO.

"These findings are potentially important for clinicians, laboratory professionals and policy-makers as it gives them a better idea of which tests may deliver the best results and how to ensure the tests they are using are properly matched to the virus genome," says Khan.

The study was funded by the Canadian Institutes of Health Research.


Story Source:

Materials provided by York University. Note: Content may be edited for style and length.


Journal Reference:

  1. Kashif Aziz Khan, Peter Cheung. Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome. Royal Society Open Science, 2020; 7 (6): 200636 DOI: 10.1098/rsos.200636

Cite This Page:

York University. "Putting COVID-19 diagnostic tests to the 'test' -- how do they hold up?." ScienceDaily. ScienceDaily, 10 June 2020. <www.sciencedaily.com/releases/2020/06/200610094100.htm>.
York University. (2020, June 10). Putting COVID-19 diagnostic tests to the 'test' -- how do they hold up?. ScienceDaily. Retrieved October 15, 2024 from www.sciencedaily.com/releases/2020/06/200610094100.htm
York University. "Putting COVID-19 diagnostic tests to the 'test' -- how do they hold up?." ScienceDaily. www.sciencedaily.com/releases/2020/06/200610094100.htm (accessed October 15, 2024).

Explore More

from ScienceDaily

RELATED STORIES